Liver Cancer Trial, Recruiting (NCT05502198)

Liver Cancer Trial, Recruiting NCT05502198 Sponsor: Linkoeping University Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05502198 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with, or are suspected to have, liver cirrhosis (scarring of the liver), as determined by doctors at the Department of Gastroenterology and Hepatology at Linköping University Hospital — this may be based on different types of tests, scans, or symptoms, and does not have to be confirmed by a tissue biopsy.
You are 18 years of age or older.
You are willing and able to give written consent to take part in the trial.

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan (for example, having certain metal implants — confirm with trial site).
You have a condition called primary sclerosing cholangitis (PSC), which is a disease that causes scarring of the bile ducts in the liver.
You have been diagnosed with liver cancer (hepatocellular carcinoma/HCC).
You have previously had a liver transplant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mattias Ekstedt, MD, PhD, Linkoeping University

Phone: +46709296267

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05502198

Sponsor: Linkoeping University

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: +46709296267

More information: https://clinicaltrials.gov/study/NCT05502198

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with, or are suspected to have, liver cirrhosis (scarring of the liver), as determined by doctors at the Department of Gastroenterology and Hepatology at Linköping University Hospital — this may be based on different types of tests, scans, or symptoms, and does not have to be confirmed by a tissue biopsy.
You are 18 years of age or older.
You are willing and able to give written consent to take part in the trial.

Who may not be able to join:

You have a medical reason why you cannot have an MRI scan (for example, having certain metal implants — confirm with trial site).
You have a condition called primary sclerosing cholangitis (PSC), which is a disease that causes scarring of the bile ducts in the liver.
You have been diagnosed with liver cancer (hepatocellular carcinoma/HCC).
You have previously had a liver transplant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Linkoeping University

Registry

ClinicalTrials.gov

Start date

1 February 2021

Est. completion

30 June 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Body composition (FFMVvcg); Body composition (FFMVvcg); Body composition (FFMVvcg); Body composition (FFMVvcg); Change from baseline Body composition (FFMVvcg); Change from 6 months Body composition (FFMVvcg); Change from 1 year Body composition (FFMVvcg); Muscle fat infiltration (%) [MFI]; Muscle fat infiltration (%) [MFI]; Muscle fat infiltration (%) [MFI]; Muscle fat infiltration (%) [MFI]; Change from baseline Muscle fat infiltration (%) [MFI]; Change from 6 months Muscle fat infiltration (%) [MFI]; Change from 1 year Muscle fat infiltration (%) [MFI]; Presence of previous decompensation;...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov